The Latest Biotech IPO - $150 million

Autolus Therapeutics plc (“Autolus”) announced on 6/22/2018 the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares (“ADSs”) representing 8,823,530 ordinary shares at an initial public offering price of $17.00 per ADS for total gross proceeds of approximately $150.0 million.